Evaluating blood markers in children with lupus
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients : Correlation With Disease Activity and Chronic Organ Damage in These Patients
This study looks at blood markers in children with lupus to see how they relate to the severity of the disease and any long-term damage it may cause.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06718283 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the relationship between various hematologic indices in children diagnosed with juvenile systemic lupus erythematosus (SLE) and their correlation with disease activity and chronic organ damage. Researchers will calculate important indices such as the systemic inflammatory index and correlate these with established disease activity and damage indices. The observational nature of the study allows for a comprehensive analysis of these relationships without any interventions.
Who should consider this trial
Good fit: Ideal candidates are children diagnosed with juvenile systemic lupus erythematosus who meet specific diagnostic criteria.
Not a fit: Patients with adult-onset lupus or other chronic inflammatory disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable biomarkers for monitoring disease activity and organ damage in juvenile lupus patients.
How similar studies have performed: While there have been studies on hematologic indices in lupus, this specific correlation in juvenile patients is less explored, making this approach somewhat novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus * Age of patients at disease onset before 18 years Exclusion Criteria: * Adult onset disease ( age at disease onset after 18 years * Any other chronic inflamatory disorders or other autoimmune diseases
Where this trial is running
Sohag
- Faculty of medicine — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Alshimaa H Khalaf
- Email: elshimaa011054@med.sohag.edu.eg
- Phone: 01067790054
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.